[ad_1] The S&P 500 finished the year on a high note in December as positive economic data, falling inflation and the possibility of 2024 interest rate cuts boosted investor sentiment.…
Tag: ImmunoGen
$19 Billion in a Week: AbbVie Makes Two Big Bets
[ad_1] Early last week, AbbVie was on every healthcare investment banker’s list. But with two quick deal announcements under its belt in just six days, AbbVie may have transformed its…
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
[ad_1] Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie…